Format

Send to

Choose Destination
Cancer Cell. 2012 Oct 16;22(4):419-20. doi: 10.1016/j.ccr.2012.09.024.

Cell cycle-based therapies move forward.

Author information

1
Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain. malumbres@cnio.es

Abstract

Targeted therapies directed against cell cycle regulators have been difficult to translate into the clinic. In this issue of Cancer Cell, Choi et al. and Sawai et al. rekindle the therapeutic value of inhibiting specific cyclin-dependent kinase complexes by demonstrating their requirements in the maintenance of breast tumors and leukemias.

PMID:
23079651
DOI:
10.1016/j.ccr.2012.09.024
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center